GeneFirst dispose d’un riche portefeuille de technologies brevetées, à savoir:
- MPA (multiplex Probe Amplification)
- TBD-Seq (Tagged BiDirectional Sequencing)
- MMD-PCR (Multiplex Mutation Detection PCR)
- PCDR (Polymerase Chain Displacement Reaction)
Human papillomavirus (HPV) and Cervical cancer
Cell-free DNA in plasma and Cancer
Voir les publications sur la gamme
